Continuing anti-tumor necrosis factor (anti-TNF) therapy after 24 weeks of pregnancy is associated with a lower likelihood of relapse of inflammatory bowel disease (IBD) in pregnant women and fewer ...
Content warning: This article contains sensitive discussion of baby loss, which some readers may find upsetting. Please take care while reading and consider whether this content is right for you at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results